Not for distribution, directly or indirectly, in the United States, Canada, Australia or Japan
Paris, 14 March 2018 – Altamir and Financière Hélios, its subsidiary, have launched today the sale of 2,000,000 Albioma shares, representing approximately 6.6 % of the company's share capital.
The transaction will be conducted via an institutional private placement by way of an accelerated bookbuilding.
The bookbuilding will start immediately; the results of the private placement will be announced after the close of the bookbuilding process.
Following the placement, Altamir will not keep any Albioma shares and Financière Hélios will keep 5.6% of Albioma share capital.
Financière Hélios has granted to the Bookrunner of the placement a 90-day lock-up, subject to certain exceptions.
Albioma shares are listed on the regulated market of Euronext Paris (isin FR0000060402).
As long-term investor, Altamir has backed Albioma's development since 2005, first with Apax Partners, then as main shareholder. Over this period, Albioma doubled its production capacity, its sales revenue and its EBITDA, and successfully established in Brazil in 2014.
This press release does not constitute an offer to sell or a solicitation to buy any securities, and the offer of Albioma shares by Altamir and Financière Hélios does not constitute a public offering.
* * * * * * * * * *
About Altamir
Altamir is a listed private equity company (Euronext Paris-B, ticker: LTA) founded in 1995 and with nearly €800m in assets under management. Its objective is to provide shareholders with long term capital appreciation and regular dividends by investing in a diversified portfolio of private equity investments.
Altamir's investment policy is to invest via and with the funds managed by Apax Partners SAS and Apax Partners LLP, two leading private equity firms that take majority or lead positions in buyouts and growth capital transactions and seek ambitious value creation objectives.
In this way, Altamir provides access to a diversified portfolio of fast-growing companies across Apax's sectors of specialisation (TMT, Consumer, Healthcare, Services) and in complementary market segments (mid-sized companies in French-speaking European countries and larger companies across Europe, North America and key emerging markets).
Altamir derives certain tax benefits from its status as an SCR ("Société de Capital Risque"). As such, Altamir is exempt from corporate tax and the company's investors may benefit from tax exemptions, subject to specific holding-period and dividend-reinvestment conditions.
For more information: www.altamir.fr
Contact
Agathe Heinrich
Tél. : +33 1 53 65 01 74
E-mail: agathe.heinrich@altamir.fr
Disclaimer
This announcement is for information purposes only and does not constitute an offer to sell or a solicitation to buy any securities, and the offer of Albioma shares by Altamir and Financière Hélios does not constitute a public offering in any jurisdiction, including in France.
This communication is for distribution in the United Kingdom only to (i) investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (ii) high net worth entities and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons").
The offer and sale of the securities referred to in this announcement has not been, nor will be, registered under the United States Securities Act of 1933 (the "Securities Act") and the securities may not be offered or sold in the United States absent such registration or an applicable exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States in connection with this transaction.
Any investment decision to buy shares in Albioma must be made solely on the basis of publicly available information regarding Albioma. Such information is not the responsibility of Altamir and Financière Hélios.
Release, publication or distribution of this press release is forbidden in any country where it would violate applicable laws or regulations. This press release may not be published, forwarded or distributed, directly or indirectly, in the United States, Canada, Australia or Japan.
